Clinical Trials in Nashville

Showing 18281-18300 of 20,298 trials

Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic Cancer

NCT00897832

RATIONALE: Studying samples of tumor tissue in the laboratory from patients with cancer may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This laboratory study is looking at biomarkers in predicting response to treatment in patients who have undergone surgery for pancreatic cancer.

Pancreatic Cancer

Vanderbilt-Ingram Cancer Center50 participantsStarted Jan 2007

Nashville, Tennessee, United States • Nashville, Tennessee, United States • Nashville, Tennessee, United States

TERMINATEDNA< 1 mile

Celecoxib in Treating Patients With Early-Stage Rectal Cancer

NCT00608595

RATIONALE: Studying samples of tissue, blood, and urine from patients with cancer in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how rectal cancer will respond to treatment with celecoxib. PURPOSE: This clinical trial is studying how well celecoxib works in treating patients with early-stage rectal cancer.

Colorectal Cancer

Vanderbilt-Ingram Cancer Center10 participantsStarted Jul 2002

Nashville, Tennessee, United States • Nashville, Tennessee, United States

Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic Cancer

Celecoxib in Treating Patients With Early-Stage Rectal Cancer

Find Trials by Condition in Nashville

Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery

Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer

Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3

Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation

Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy Volunteers

A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

A Study Of Different Doses Of TBC3711 In Patients With Uncontrolled High Blood Pressure Already Taking Medications For High Blood Pressure.

Chemotherapy in Treating Patients With Recurrent Malignant Glioma

Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection

Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection

Feasibility And Safety Study Of rhBMP-2/CPM For Hip Fractures

Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women

A Study of MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients

Contralateral Comparison of Three Excimer Laser Systems in Performing LASIK

Effect of Orlistat in Body Composition

Establishing a Standard for Peri-operative Implantable Cardioverter Defibrillator (ICD) Patient Education

Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic Therapy

Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis (MPS) I